KSWWM
ABBV icon

Keyes Stange & Wooten Wealth Management’s AbbVie ABBV Stock Holding History

Keyes Stange & Wooten Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$768K Sell
3,052
-47
-2% -$10.1K 0.31% 29
2026
Q1 		$674K Buy
3,099
+105
+4% +$23.3K 0.3% 33
2025
Q4 		$684K Sell
2,994
-117
-4% -$26.7K 0.32% 29
2025
Q3 		$720K Sell
3,111
-3
-0.1% -$611 0.35% 30
2025
Q2 		$578K Buy
+3,114
New +$579K 0.3% 40

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Keyes Stange & Wooten Wealth Management's ABBV Position: Q2 2026 in Review

Keyes Stange & Wooten Wealth Management reduced its AbbVie (ABBV) stake by 1.5% in Q2 2026, selling an estimated $10.1K and leaving 3,052 shares worth $768K. The position accounts for 0.31% of the portfolio, ranked #29.

Keyes Stange & Wooten Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Keyes Stange & Wooten Wealth Management held 3,052 shares of AbbVie worth $768K as of Q2 2026.
  • Keyes Stange & Wooten Wealth Management sold 47 AbbVie shares in Q2 2026, an estimated $10.1K.
  • AbbVie made up 0.31% of Keyes Stange & Wooten Wealth Management's portfolio in Q2 2026, its #29 holding.
  • Keyes Stange & Wooten Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Keyes Stange & Wooten Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.